• news-banner

    Expert Insights

Focus Antitrust - 11 June 2020

In The News

CMA obtains director disqualification undertakings from pharmaceutical company director

The CMA has obtained director disqualification undertakings from a director of pharmaceutical companies involved in the CMA’s investigations into agreements relating to the supply of nortriptyline and fludrocortisone. Click here.

Advocate General advises upholding Lundbeck pay for delay decision

An Advocate General’s opinion has proposed that the ECJ should uphold the European Commission’s decision in the Lundbeck pay for delay case. Click here.

European Commission sends supplementary Statement of Objections to Teva on suspected 'pay-for-delay' pharma agreement

The European Commission has sent a supplementary Statement of Objections to Teva Pharmaceutical Industries Ltd. and Cephalon Inc., now a subsidiary of Teva. It follows the Commission's original Statement of Objections, in which the Commission had reached the preliminary conclusion that the patent settlement agreement between Cephalon and Teva concerning the sleeping disorder medicine modafinil may have delayed the entry of a cheaper generic medicine, in breach of Article 101. Click here.

EU

Mergers
  • The European Commission has approved the proposed acquisition of Bayer AGs animal health division by Elanco Animal Health Inc. The decision is conditional on the divestment of otitis products and several types of parasiticides in the European Economic Area, the UK and globally. Click here.

UK

CMA
  • The CMA has published an updated case timetable following the remittal by the Court of Appeal of its investigation into alleged excessive and unfair prices for phenytoin sodium capsules. Click here.

Our thinking

  • IBA Annual Conference 2024

    Charlotte Ford

    Events

  • LIDW: Is arbitration an effective process for disputes involving state interests: a panel discussion of concerns raised in Nigeria v. P&IDL [2023] EWHC 2638

    Richard Kiddell

    Events

  • LIDW: An Era of Constant Change – an event to explore the General Counsel’s role in delivering sustainable growth whilst managing global ESG risks

    Caroline Greenwell

    Events

  • LIDW: Liability imposed on UK Directors and how to mitigate the risks

    Claudine Morgan

    Events

  • Property Patter - Great Estates Miniseries - part 1

    Cara Imbrailo

    Podcasts

  • The Telegraph quotes Dominic Lawrance on Labour’s proposed expansion of rules governing trusts

    Dominic Lawrance

    In the Press

  • How is trust reporting under the Register of Overseas Entities changing after 4 June 2024?

    Jack Carter

    Insights

  • Relocation to Italy: Italian Lump Sum Tax Regime

    Nicola Saccardo

    Insights

  • The Law Society Gazette and CDR Magazine quote Caroline Greenwell on the LIBOR appeal

    Caroline Greenwell

    In the Press

  • Charles Russell Speechlys advises long standing client AgDevCo on its equity investment in Agris

    Adrian Mayer

    News

  • The UK government updates on timings for Sustainability Disclosure Requirements components

    Megan Gray

    Quick Reads

  • Consequences of Disobeying Court Orders?

    Stephen Chan

    Insights

  • Lights, Camera, Rebates: A Closer Look at Film Financing in the Gulf

    Mark Hill

    Quick Reads

  • Disputes Matters: International Arbitration

    Thomas R. Snider

    Podcasts

  • CDR Magazine quotes Stewart Hey on the cum-ex scandal

    Stewart Hey

    In the Press

  • Using Generative AI and staying on the right side of the law

    Rebecca Steer

    Insights

  • World Trademark Review quotes Charlotte Duly on a recent Supreme Court director liability ruling

    Charlotte Duly

    In the Press

  • FE News quotes Adam Kyte on the MAC's review of the graduate visa route

    Adam Kyte

    In the Press

  • Amendments to the Swiss Civil Procedure Code: Enhancing International Litigation and Streamlining Processes

    Remo Wagner

    Quick Reads

  • The Building Safety Act 2022 – Considerations for Real Estate Lenders

    James Walton

    Insights

Back to top